{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:21:11Z","timestamp":1780435271909,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"am","delay-in-days":248,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.parint.2024.102941","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T02:25:59Z","timestamp":1722651959000},"page":"102941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluation of the inhibitory effects of sitamaquine on Babesia infections"],"prefix":"10.1016","volume":"103","author":[{"given":"Dongxue","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuna","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloiza May","family":"Galon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuenan","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2024.102941_bb0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.vetpar.2006.01.048","article-title":"Chemotherapy against babesiosis","volume":"138","author":"Vial","year":"2006","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.parint.2024.102941_bb0010","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/cid\/cix477","article-title":"Clinical and molecular evidence of atovaquone and azithromycin resistance in relapsed Babesia microti infection associated with rituximab and chronic lymphocytic leukemia","volume":"65","author":"Simon","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.parint.2024.102941_bb0015","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","article-title":"Primaquine revisited six decades after its discovery","volume":"44","author":"Vale","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.parint.2024.102941_bb0020","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3855\/jidc.5500","article-title":"Inhibitory effects of 19 antiprotozoal drugs and antibiotics on Babesia microti infection in BALB\/c mice","volume":"9","author":"Yao","year":"2015","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.parint.2024.102941_bb0025","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s40265-018-0979-2","article-title":"Tafenoquine: first global approval","volume":"78","author":"Frampton","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.parint.2024.102941_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00204-21","article-title":"Tafenoquine is a promising drug candidate for the treatment of babesiosis","volume":"65","author":"Liu","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2024.102941_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-021-05127-0","article-title":"Inhibitory effect of naphthoquine phosphate on Babesia gibsoni in vitro and Babesia rodhaini in vivo","volume":"15","author":"Ji","year":"2022","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.parint.2024.102941_bb0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1051\/parasite\/2011182115","article-title":"Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance","volume":"18","author":"Loiseau","year":"2011","journal-title":"Parasite"},{"key":"10.1016\/j.parint.2024.102941_bb0045","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4269\/ajtmh.2011.10-0409","article-title":"Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniasis: a randomized study in Bihar, India","volume":"84","author":"Sundar","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2024.102941_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2020.102054","article-title":"Closing the empty anti-Babesia gibsoni drug pipeline in vitro using fluorescence-based high throughput screening assay","volume":"75","author":"Rizk","year":"2020","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.parint.2024.102941_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.vetpar.2004.07.005","article-title":"Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro","volume":"124","author":"Matsuu","year":"2004","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.parint.2024.102941_bb0060","doi-asserted-by":"crossref","first-page":"1048962","DOI":"10.3389\/fcimb.2022.1048962","article-title":"Phosphatidylinositol 4-kinase is a viable target for the radical cure of Babesia microti infection in immunocompromised hosts","volume":"12","author":"Ji","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.parint.2024.102941_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1128\/AAC.41.1.91","article-title":"Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model","volume":"41","author":"Marley","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2024.102941_bb0070","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1177\/106002809302701215","article-title":"Atovaquone: a review","volume":"27","author":"Halie","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.parint.2024.102941_bb0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.biopha.2007.12.006","article-title":"Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani","volume":"62","author":"Bories","year":"2008","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.parint.2024.102941_bb0080","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1128\/AAC.00964-08","article-title":"Sitamaquine sensitivity in Leishmania species is not mediated by drug accumulation in acidocalcisomes","volume":"52","author":"L\u00f3pez-Mart\u00edn","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2024.102941_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-5793(00)01531-3","article-title":"Presence of a Na(+)\/H(+) exchanger in acidocalcisomes of Leishmania donovani and their alkalization by anti-leishmanial drugs","volume":"473","author":"Vercesi","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.parint.2024.102941_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.exppara.2007.07.009","article-title":"Acidocalcisomes in Apicomplexan parasites","volume":"118","author":"Miranda","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.parint.2024.102941_bb0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/bj2840463","article-title":"Ca2+ transport by digitonin-permeabilized Leishmania donovani. Effects of Ca2+, pentamidine and WR-6026 on mitochondrial membrane potential in situ","volume":"284","author":"Vercesi","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.parint.2024.102941_bb0100","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/AAC.00520-11","article-title":"8-Aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donvani promastigotes by targeting succinate dehydrogenase","volume":"55","author":"Carvalho","year":"2011","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576924000928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576924000928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T05:40:34Z","timestamp":1730871634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576924000928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":20,"alternative-id":["S1383576924000928"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2024.102941","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the inhibitory effects of sitamaquine on Babesia infections","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2024.102941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102941"}}